Lindis Blood Care GmbH | WebDisclosure

BRIEF

published on 12/12/2024 at 10:05, 9 days 8 hours ago

Lindis Blood Care Secures Funding for CATUVAB® Development

Medical Device Clinical Study Funding Round Cancer Surgery Market Launch
BRIEF

published on 12/12/2024 at 10:05, 9 days 8 hours ago

Lindis Blood Care obtient un financement pour le développement de CATUVAB®

Étude Clinique Dispositif Médical Chirurgie Du Cancer Tour De Financement Lancement Sur Le Marché
PRESS RELEASE

published on 12/12/2024 at 10:00, 9 days 8 hours ago

Lindis Blood Care Announces Successful Financing for its Tumor-Cell-Removal Medical Device, CATUVAB®
Lindis Blood Care secures financing for CATUVAB(R) tumor-cell-removal device, aiming at cancer surgery safety and efficacy enhancements

Financing Medical Device Lindis Blood Care CATUVAB Tumor-cell-removal
BRIEF

published on 04/22/2024 at 14:05, 7 months 29 days ago

Lindis Blood Care Announces Success in REMOVE Clinical Study with CATUVAB® for Cancer Surgeries

CATUVAB® Cancer Surgery REMOVE Clinical Study Autologous Blood Transfusion Market Authorization
BRIEF

published on 04/22/2024 at 14:05, 7 months 29 days ago

Lindis Blood Care annonce le succès de l'étude clinique REMOVE avec CATUVAB® pour les chirurgies cancéreuses

Autorisation De Mise Sur Le Marché CATUVAB® Chirurgie Du Cancer SUPPRIMER L'étude Clinique Transfusion Sanguine Autologue
PRESS RELEASE

published on 04/22/2024 at 14:00, 7 months 29 days ago

Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB® to Enable Autologous Blood Transfusions in Cancer Surgeries
Lindis Blood Care announces positive results from the REMOVE study showcasing the effectiveness of CATUVAB(R) in enabling autologous blood transfusions during cancer surgeries

Lindis Blood Care REMOVE Study CATUVAB Autologous Blood Transfusions Cancer Surgeries
BRIEF

published on 04/11/2024 at 14:05, 8 months 10 days ago

Lindis Blood Care to Unveil REMOVE Study Results on CATUVAB® at NATA24 Symposium

Lindis Blood Care CATUVAB® REMOVE Study NATA24 Symposium Cancer Surgery
BRIEF

published on 04/11/2024 at 14:05, 8 months 10 days ago

Lindis Blood Care dévoilera les résultats de l'étude REMOVE sur CATUVAB® lors du symposium NATA24

CATUVAB® Soins Du Sang Lindis SUPPRIMER L'étude Symposium NATA24 Chirurgie Du Cancer
PRESS RELEASE

published on 04/11/2024 at 14:00, 8 months 10 days ago

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium
Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB at NATA24 Annual Symposium in Bologna, Italy. Prof. Dr. med. Patrick Meybohm to present safety and efficacy data

Lindis Blood Care CATUVAB NATA24 Annual Symposium Clinical Certification Study Tumor Cells

Published on 12/21/2024 at 01:30, 17 hours 18 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 18 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 43 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 48 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 18 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 17 hours 57 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 3 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 38 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 52 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 31 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 31 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News